139 related articles for article (PubMed ID: 23143735)
1. Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease.
Otgonsuren M; Stepanova M; Gerber L; Younossi ZM
Dig Dis Sci; 2013 Apr; 58(4):1132-40. PubMed ID: 23143735
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease in lean individuals in the United States.
Younossi ZM; Stepanova M; Negro F; Hallaji S; Younossi Y; Lam B; Srishord M
Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.
Lazo M; Hernaez R; Eberhardt MS; Bonekamp S; Kamel I; Guallar E; Koteish A; Brancati FL; Clark JM
Am J Epidemiol; 2013 Jul; 178(1):38-45. PubMed ID: 23703888
[TBL] [Abstract][Full Text] [Related]
5. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
[TBL] [Abstract][Full Text] [Related]
6. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
Stepanova M; Younossi ZM
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
[TBL] [Abstract][Full Text] [Related]
7. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
8. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).
Golabi P; Stepanova M; Pham HT; Cable R; Rafiq N; Bush H; Gogoll T; Younossi ZM
BMJ Open Gastroenterol; 2018; 5(1):e000198. PubMed ID: 29607054
[TBL] [Abstract][Full Text] [Related]
10. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.
Atsawarungruangkit A; Chenbhanich J; Dickstein G
World J Gastroenterol; 2018 Aug; 24(32):3663-3670. PubMed ID: 30166861
[TBL] [Abstract][Full Text] [Related]
11. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
12. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups.
Smits MM; Ioannou GN; Boyko EJ; Utzschneider KM
J Gastroenterol Hepatol; 2013 Apr; 28(4):664-70. PubMed ID: 23286209
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community.
Onyekwere CA; Ogbera AO; Balogun BO
Ann Hepatol; 2011; 10(2):119-24. PubMed ID: 21502672
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis in obese Chinese children.
Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
[TBL] [Abstract][Full Text] [Related]
16. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in nonalcoholic fatty liver disease in the U.S. population.
Schneider AL; Lazo M; Selvin E; Clark JM
Obesity (Silver Spring); 2014 Jan; 22(1):292-9. PubMed ID: 23512725
[TBL] [Abstract][Full Text] [Related]
18. Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease.
Subramanian V; Johnston RD; Kaye P; Aithal GP
Aliment Pharmacol Ther; 2013 Feb; 37(4):455-63. PubMed ID: 23293873
[TBL] [Abstract][Full Text] [Related]
19. Prediction of nonalcoholic fatty liver disease using anthropometry and body fat measures by sex and race/ethnicity in the United States.
Jones GS; Graubard BI; Alvarez CS; McGlynn KA
Obesity (Silver Spring); 2022 Sep; 30(9):1760-1765. PubMed ID: 35945693
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study.
Gerber L; Otgonsuren M; Mishra A; Escheik C; Birerdinc A; Stepanova M; Younossi ZM
Aliment Pharmacol Ther; 2012 Oct; 36(8):772-81. PubMed ID: 22958053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
